Teoretisk hæmmes metabolismen af toremifen af lægemidler, som hæmmer enzymsystemet CYP 3A, idet dette er rapporteret til at være dets hovedmetabolisme.
Theoretically the metabolism of toremifene is inhibited by drugs known to inhibit the CYP 3A enzyme system which is reported to be responsible for its main metabolic pathways.